Sodium‐glucose cotransporter 2 inhibitor ameliorates thiazolidinedione‐induced fluid retention through vascular leakage reduction in white adipose tissue
Our results suggest that SGLT2is protect against TZD-induced fluid retention by preserving vascular integrity in WAT, providing a viable therapeutic strategy to minimise TZD-associated side effects.
Authors
- Dong‐Hoon Kim (ORCID: https://orcid.org/0000-0002-7848-4311)
- Hyemin Jang (ORCID: https://orcid.org/0000-0003-3152-1274)
- Sin Gon Kim (ORCID: https://orcid.org/0000-0002-7430-3675)
- Hye‐Jin Lee (ORCID: https://orcid.org/0000-0002-7800-7101)
- Nam Hoon Kim (ORCID: https://orcid.org/0000-0002-9926-1344)
- Ji Yoon Kim
- Amanda Lee (ORCID: https://orcid.org/0000-0002-6708-4566)
Institutions
- Korea University (KR)
- Samsung Medical Center (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1111/dom.70356
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00